The infraorbital area plays a crucial role in non-verbal signalling of health and vitality. The periorbital area can impact perceived attractiveness [1] and affect self-confidence, as structural changes can make individuals look sad, tired or unwell. Infraorbital (IO) hyaluronic acid (HA) filler injections have rapidly gained popularity, since they were first used in 2005, due to their minimally invasive nature and immediate results. The “tear trough area” of IO hollows were rated as the second most likely area to be treated in the 30- to 34-year age group and third most likely facial area to be treated and all age groups [2]. However, the complex nature of IO anatomy, its assessment and the rising risk of complications have made practitioners and patients wary of undertaking these treatments.